Pharmacokinetics, Pharmacodynamics and Safety of Alogliptin in Children, Adolescents and Adults With Type 2 Diabetes Mellitus - Trial 2009-011221-13
Access comprehensive clinical trial information for 2009-011221-13 through Pure Global AI's free database. This phase not specified trial is sponsored by Takeda Global Research & Development Center, Inc. and is currently status unknown. The study focuses on Type 2 diabetes mellitus.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Takeda Global Research & Development Center, Inc.
Timeline & Enrollment
N/A
N/A
N/A
Primary Outcome
• Is currently participating in another investigational study or has taken an investigational drug within 30 days prior to Day 1.
ICD-10 Classifications
Data Source
EU Clinical Trials Register
2009-011221-13
Non-Device Trial